Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Fox News28d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Medscape1mon
FDA Approves Second Generic Daily GLP-1 Drug for T2D
The US Food and Drug Administration has approved a generic once ... type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last month of a generic version ...
The Spokesman-Review27d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
What foods use Red Dye No. 3? What to know about the newly banned food coloring
Red Dye No. 3, also known as erythrosine, is a synthetic food dye that gives foods and drinks a bright red color. It is also ...
New York Post27d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The the US Food and Drug Administration (FDA) has approved the first medication to ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...
WDSU1mon
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
It should be used with a reduced-calorie diet and ... the new FDA green light doesn't expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...